Papers: 10.1186/s12935-020-01431-4
https://doi.org/10.1186/s12935-020-01431-4
Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines
Cited by: 4
Author(s): Lisa-Madeleine Sklarz, Yvonne Saara Gladbach, Markus Ernst, Maaweya E. Hamed, Catrin Roolf, Sina Sender, Julia Beck, Ekkehard Schütz, Stefan Fischer, Stephan Struckmann, Christian Junghanß, Georg Fuellen, Hugo Murua Escobar
Published: over 6 years ago
Software Mentions 1
Very Likely Science (90)